Search results
Results from the WOW.Com Content Network
MBA Programme of Savitribai Phule Pune University at Sub-Centre Nashik operating under the highly well-endowed guidance of PUMBA. MBA Programme of Savitribai Phule Pune University at Sub-Centre Nashik initiated in 2018. The course duration is 2 years. It consists of 4 semesters spread over 2 years. The intake of the MBA Programme is 60.
National Institute of Pharmaceutical Education and Research (NIPERs) are a group of national level institutes of pharmaceutical sciences or Pharmacy school in India.
A consultant pharmacist is a pharmacist who works as a consultant providing expert advice on clinical pharmacy, academic pharmacy or practice, public health pharmacy, industrial pharmacy, community pharmacy or practice, pharmaceutical analysis etc., regarding the safe use and production of medications or on the provision of pharmaceutical services to medical institutions, hospitals ...
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai.Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. [3]
Sun Pharmaceutical Industries Ltd. was established by Dilip Shanghvi in 1983 in Calcutta, West Bengal with five psychiatry products and a two-person marketing team. Today it is ranked number one in share of prescriptions with 12 classes of doctors in India and a market leader in Psychiatry, Neurology, Cardiology, Orthopaedics, Gastroenterology, Nephrology, Diabetology, Dermatology, Urology ...
[2] [3] It offers 2-year MS (Pharm.) programmes [4] and doctoral programmes in pharmaceutical sciences. [5] On 2016 Institute pact with Sanofi India to promote academic excellence and research in the areas of pharmaceuticals and consumer healthcare products, to cater to the current and future needs of the pharmaceutical industry. [6]
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. [1] India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports.
Serum Institute of India partnered with the British-Swedish multinational pharmaceutical company AstraZeneca for developing AZD1222 (Covishield) in partnership with the University of Oxford. [19] It was reported that Serum Institute of India would provide 100 million (10 crore) doses of the vaccine for India and other low and middle-income ...